Business
Telix Resubmits NDA to FDA for Pixclara Brain Cancer Imaging
Telix Resubmits NDA to FDA for Pixclara Brain Cancer Imaging
About this update from Telix Pharmaceuticals Limited
[{"type":"text","content":"Telix Pharmaceuticals Ltd has released a press release. View Attachment","length":255,"tagName":"div"}]